Alain Bitton

27.3k total citations · 1 hit paper
203 papers, 7.1k citations indexed

About

Alain Bitton is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Alain Bitton has authored 203 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Genetics, 108 papers in Epidemiology and 71 papers in Surgery. Recurrent topics in Alain Bitton's work include Inflammatory Bowel Disease (145 papers), Microscopic Colitis (86 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Alain Bitton is often cited by papers focused on Inflammatory Bowel Disease (145 papers), Microscopic Colitis (86 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Alain Bitton collaborates with scholars based in Canada, United States and Hungary. Alain Bitton's co-authors include Waqqas Afif, Gary Wild, Ernest G. Seidman, Talat Bessissow, Çharles N. Bernstein, Brian G. Feagan, Albert Cohen, Maida Sewitch, Paul Brassard and Geoffrey C. Nguyen and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Alain Bitton

188 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

2015 311 citations Geoffrey C. Nguyen, Jennifer Jones et al. Gastroenterology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alain Bitton	4.6k	3.4k	2.3k	1.4k	736	203	7.1k
Corey A. Siegel	5.1k 1.1×	3.9k 1.1×	1.7k 0.8×	1.5k 1.1×	998 1.4×	274	7.3k
Subra Kugathasan	5.1k 1.1×	3.4k 1.0×	2.2k 0.9×	1.7k 1.2×	616 0.8×	175	7.8k
Adam S. Cheifetz	4.9k 1.1×	3.6k 1.1×	1.9k 0.9×	2.3k 1.6×	821 1.1×	213	7.7k
Fernando Magro	5.5k 1.2×	4.2k 1.2×	2.4k 1.1×	1.5k 1.1×	648 0.9×	307	8.6k
Gionata Fiorino	4.5k 1.0×	3.3k 1.0×	1.9k 0.8×	1.9k 1.3×	650 0.9×	255	7.0k
A. Hillary Steinhart	6.5k 1.4×	5.1k 1.5×	2.3k 1.0×	1.5k 1.1×	725 1.0×	146	8.5k
Pia Munkholm	5.3k 1.2×	4.0k 1.2×	2.5k 1.1×	842 0.6×	673 0.9×	110	7.2k
Johan Burisch	5.1k 1.1×	3.6k 1.1×	2.2k 1.0×	991 0.7×	510 0.7×	233	7.6k
Gil Melmed	3.8k 0.8×	3.0k 0.9×	1.8k 0.8×	1.6k 1.2×	447 0.6×	305	7.1k
Brian Bressler	4.5k 1.0×	3.8k 1.1×	2.2k 1.0×	1.9k 1.3×	664 0.9×	237	7.8k

Countries citing papers authored by Alain Bitton

Since Specialization

Citations

This map shows the geographic impact of Alain Bitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Bitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Bitton more than expected).

Fields of papers citing papers by Alain Bitton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Bitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Bitton. The network helps show where Alain Bitton may publish in the future.

Co-authorship network of co-authors of Alain Bitton

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Bitton. A scholar is included among the top collaborators of Alain Bitton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Bitton. Alain Bitton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noh, Yunha, et al.. (2025). Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes. Annals of Internal Medicine. 178(9). 1268–1278. 3 indexed citations

Afif, Waqqas, Alain Bitton, Gary Wild, et al.. (2024). P716 Efficacy and safety of upadacitinib during induction in Crohn’s disease: Real-world experience. Journal of Crohn s and Colitis. 18(Supplement_1). i1337–i1337. 1 indexed citations

Bernstein, Çharles N., Remo Panaccione, Zoann Nugent, et al.. (2024). Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study. Inflammatory Bowel Diseases. 31(1). 113–122. 1 indexed citations

Turpin, Williams, Oren Ledder, Anne M. Griffiths, et al.. (2024). P244 The first step to IBD prevention exploring rate of pre-clinical inflammation in subset of asymptomatic subjects at risk of IBD: screening stage of the PIONIR trial. Journal of Crohn s and Colitis. 18(Supplement_1). i585–i586. 1 indexed citations

Wetwittayakhlang, Panu, Christine Verdon, Michael Starr, et al.. (2023). Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study. The Turkish Journal of Gastroenterology. 34(6). 603–610. 1 indexed citations

Coward, Stephanie, Eric I. Benchimol, C N Bernstein, et al.. (2023). A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS. Journal of the Canadian Association of Gastroenterology. 6(Supplement_1). 14–15.

Singh, H.B., Alain Bitton, Gilaad G. Kaplan, et al.. (2023). A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY. Journal of the Canadian Association of Gastroenterology. 6(Supplement_1). 27–28.

Wetwittayakhlang, Panu, Waqqas Afif, Gary Wild, et al.. (2023). Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study. Digestive and Liver Disease. 56(1). 35–42. 10 indexed citations

Windsor, Joseph W., M Ellen Kuenzig, Sanjay K. Murthy, et al.. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary. Journal of the Canadian Association of Gastroenterology. 6(Supplement_2). S1–S8. 20 indexed citations

10.

Restellini, Sophie, Alain Bitton, Gary Wild, et al.. (2023). Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases. Crohn s & Colitis 360. 5(1). otad004–otad004. 4 indexed citations

11.

Coward, Stephanie, Eric I. Benchimol, C N Bernstein, et al.. (2023). A210 THE BURDEN OF IBD HOSPITALIZATION IN CANADA: AN ASSESSMENT OF THE CURRENT AND FUTURE BURDEN IN A NATION-WIDE ANALYSIS. Journal of the Canadian Association of Gastroenterology. 6(Supplement_1). 48–49.

12.

Wetwittayakhlang, Panu, Talat Bessissow, Waqqas Afif, et al.. (2023). P417 Frequent Early Nocebo Complaints but Maintained Clinical Efficacy, Biomarker and Therapeutic drug levels following mandatory Biosimilar Switch in Patients with Inflammatory Bowel disease: Preliminary data from a Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 17(Supplement_1). i546–i546.

13.

Buie, Michael, Stephanie Coward, Abdel Aziz Shaheen, et al.. (2023). Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study. Inflammatory Bowel Diseases. 29(10). 1536–1545. 6 indexed citations

14.

Murthy, Sanjay K., Gilaad G. Kaplan, M Ellen Kuenzig, et al.. (2023). 961 TEMPORAL TRENDS AND RELATIVE RISKS OF INTESTINAL AND EXTRAINTESTINAL CANCERS IN PERSONS WITH INFLAMMATORY BOWEL DISEASES: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE. Gastroenterology. 164(6). S–212. 1 indexed citations

15.

Golovics, Petra A., Lóránt Gönczi, Christine Verdon, et al.. (2021). P364 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: final results form a prospective study. Journal of Crohn s and Colitis. 15(Supplement_1). S381–S382.

16.

Wetwittayakhlang, Panu, Petra A. Golovics, Talat Bessissow, et al.. (2021). Clinical Outcomes of COVID‐19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 7591141–7591141. 17 indexed citations

17.

Khoury, Alex Al, Petra A. Golovics, Rita Kohen, et al.. (2021). Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. Digestive and Liver Disease. 53(8). 980–986. 5 indexed citations

18.

Gönczi, Lóránt, Zsuzsanna Kürti, Petra A. Golovics, et al.. (2017). Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies. Digestive and Liver Disease. 50(1). 37–41. 10 indexed citations

19.

Sewitch, Maida, Robert J. Hilsden, Lawrence Joseph, et al.. (2012). Qualitative Study of Physician Perspectives on Classifying Screening and Nonscreening Colonoscopy using Administrative Health Data: Adding Practice Does Not Make Perfect. SHILAP Revista de lepidopterología. 26(12). 889–893. 4 indexed citations

20.

Wang, Tiantian, David Laperrière, Hafid Soualhine, et al.. (2009). Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease. Journal of Biological Chemistry. 285(4). 2227–2231. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact